DocDollars

Neurelis, Inc.

CA · United States · Reporting entity ID 100000806859

Total reported 2019–2025
$11.6M
#449 of 2,960 reporting companies — 0% of all reported industry payments
$8.46M in general payments across 75,577 records, plus $3.15M in research funding across 364 records.

How it breaks down

General payments $8,462,288
Research funding $3,150,574

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Neurelis, Inc. reported $11.6M to US doctors and teaching hospitals from 2019 to 2025, ranking #449 of 2,960 reporting companies. 27% of that was research funding and 73% general payments such as consulting, speaking, food and travel. 75,577 general payment records and 364 research records were filed.

Common questions about Neurelis, Inc.

How much has Neurelis, Inc. paid US doctors?

Neurelis, Inc. reported $11,612,862 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $8,462,288 in general payments, $3,150,574 in research funding.

How does Neurelis, Inc. rank among drug and device companies?

It ranks #449 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Neurelis, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.